Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism
Jayasena, Channa N Anderson, Richard A Llahana, Sofia Barth, Julian H MacKenzie, Finlay Wilkes, Scott Sooriakumaran, Prasanna Minhas, Sukhbinder Wu, Frederick C W
Jayasena, Channa N
Anderson, Richard A
Llahana, Sofia
Barth, Julian H
MacKenzie, Finlay
Wilkes, Scott
Sooriakumaran, Prasanna
Minhas, Sukhbinder
Wu, Frederick C W
Citations
Altmetric:
Affiliation
Other Contributors
Publication date
2021-11-22
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Male hypogonadism (MH) is a common endocrine disorder. However, uncertainties and variations in its diagnosis and management exist. There are several current guidelines on testosterone replacement therapy that have been driven predominantly by single disciplines. The Society for Endocrinology commissioned this new guideline to provide all care providers with a multidisciplinary approach to treating patients with MH. This guideline has been compiled using expertise from endocrine (medical and nursing), primary care, clinical biochemistry, urology and reproductive medicine practices. These guidelines also provide a patient perspective to help clinicians best manage MH.
Citation
Jayasena CN, Anderson RA, Llahana S, Barth JH, MacKenzie F, Wilkes S, Smith N, Sooriakumaran P, Minhas S, Wu FCW, Tomlinson J, Quinton R. Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism. Clin Endocrinol (Oxf). 2022 Feb;96(2):200-219. doi: 10.1111/cen.14633. Epub 2021 Nov 22
Type
Article